
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AL(R) | 142 | 59.4% | -5.15 | 4 | 3.0% |
| SLP(R) | 47 | 19.7% | 0.60 | 71 | 53.4% |
| LH(R) | 42 | 17.6% | -0.11 | 39 | 29.3% |
| SCL(R) | 1 | 0.4% | 3.58 | 12 | 9.0% |
| CentralBrain-unspecified | 7 | 2.9% | -0.49 | 5 | 3.8% |
| LAL(R) | 0 | 0.0% | inf | 1 | 0.8% |
| PLP(R) | 0 | 0.0% | inf | 1 | 0.8% |
| upstream partner | # | NT | conns M_vPNml54 | % In | CV |
|---|---|---|---|---|---|
| ORN_DC2 | 15 | ACh | 54 | 24.3% | 0.6 |
| CB1160 (R) | 2 | Glu | 14 | 6.3% | 0.7 |
| M_vPNml77 (R) | 2 | GABA | 10 | 4.5% | 0.6 |
| LHPV6i2_a (R) | 1 | ACh | 9 | 4.1% | 0.0 |
| lLN2P_a (R) | 2 | GABA | 8 | 3.6% | 0.5 |
| LHPV6a9_b (R) | 3 | ACh | 8 | 3.6% | 0.5 |
| v2LN30 (R) | 1 | unc | 7 | 3.2% | 0.0 |
| ORN_VA6 | 2 | ACh | 7 | 3.2% | 0.7 |
| CB1752 (R) | 1 | ACh | 6 | 2.7% | 0.0 |
| CB2208 (R) | 2 | ACh | 6 | 2.7% | 0.7 |
| ORN_VM5d | 4 | ACh | 6 | 2.7% | 0.3 |
| VM5d_adPN (R) | 2 | ACh | 5 | 2.3% | 0.2 |
| ORN_DA2 | 3 | ACh | 5 | 2.3% | 0.3 |
| DC1_adPN (R) | 1 | ACh | 4 | 1.8% | 0.0 |
| VC4_adPN (R) | 1 | ACh | 3 | 1.4% | 0.0 |
| v2LN41 (L) | 1 | unc | 3 | 1.4% | 0.0 |
| LHPV4b3 (R) | 1 | Glu | 3 | 1.4% | 0.0 |
| DC2_adPN (R) | 1 | ACh | 3 | 1.4% | 0.0 |
| lLN2P_c (R) | 2 | GABA | 3 | 1.4% | 0.3 |
| LHPV6a3 (R) | 2 | ACh | 3 | 1.4% | 0.3 |
| lLN1_bc (R) | 3 | ACh | 3 | 1.4% | 0.0 |
| VA6_adPN (R) | 1 | ACh | 2 | 0.9% | 0.0 |
| il3LN6 (L) | 1 | GABA | 2 | 0.9% | 0.0 |
| FS4B (L) | 1 | ACh | 2 | 0.9% | 0.0 |
| M_vPNml87 (R) | 1 | GABA | 2 | 0.9% | 0.0 |
| CB3288 (R) | 1 | Glu | 2 | 0.9% | 0.0 |
| CB4084 (R) | 1 | ACh | 2 | 0.9% | 0.0 |
| CB1981 (R) | 1 | Glu | 2 | 0.9% | 0.0 |
| LHPV2b5 (R) | 1 | GABA | 2 | 0.9% | 0.0 |
| ORN_D | 2 | ACh | 2 | 0.9% | 0.0 |
| ORN_VM7v | 2 | ACh | 2 | 0.9% | 0.0 |
| M_vPNml76 (R) | 2 | GABA | 2 | 0.9% | 0.0 |
| v2LN41 (R) | 1 | unc | 1 | 0.5% | 0.0 |
| CB2224 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| M_vPNml88 (R) | 1 | GABA | 1 | 0.5% | 0.0 |
| ALBN1 (L) | 1 | unc | 1 | 0.5% | 0.0 |
| v2LN46 (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| lLN2X12 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| ORN_DC1 | 1 | ACh | 1 | 0.5% | 0.0 |
| CB1824 (R) | 1 | GABA | 1 | 0.5% | 0.0 |
| CB2600 (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| LHPV4c3 (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| CB2976 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| LHPV4c1_b (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| CB2920 (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| LHPV4g2 (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| CB3007 (R) | 1 | GABA | 1 | 0.5% | 0.0 |
| LHPD3c1 (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| LHAV2b6 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| CL255 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| LHAV2h1 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| DA2_lPN (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| D_adPN (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| DA4l_adPN (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| CSD (L) | 1 | 5-HT | 1 | 0.5% | 0.0 |
| VM7v_adPN (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| VM7d_adPN (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| lLN2P_b (R) | 1 | GABA | 1 | 0.5% | 0.0 |
| LN60 (R) | 1 | GABA | 1 | 0.5% | 0.0 |
| lLN2X11 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| lLN2F_a (R) | 1 | unc | 1 | 0.5% | 0.0 |
| lLN2F_b (R) | 1 | GABA | 1 | 0.5% | 0.0 |
| downstream partner | # | NT | conns M_vPNml54 | % Out | CV |
|---|---|---|---|---|---|
| LHPV6i2_a (R) | 1 | ACh | 33 | 12.2% | 0.0 |
| LHPV4c1_c (R) | 4 | Glu | 20 | 7.4% | 0.4 |
| SLP337 (R) | 3 | Glu | 18 | 6.7% | 0.0 |
| CB1387 (R) | 2 | ACh | 12 | 4.4% | 0.7 |
| LHPD5a1 (R) | 1 | Glu | 10 | 3.7% | 0.0 |
| CB1617 (R) | 4 | Glu | 8 | 3.0% | 0.4 |
| CB1154 (R) | 2 | Glu | 7 | 2.6% | 0.4 |
| LHPV4g2 (R) | 4 | Glu | 7 | 2.6% | 0.7 |
| M_vPNml53 (R) | 1 | GABA | 6 | 2.2% | 0.0 |
| CB4107 (R) | 1 | ACh | 5 | 1.9% | 0.0 |
| LHPV6a9_b (R) | 1 | ACh | 5 | 1.9% | 0.0 |
| CB3081 (R) | 2 | ACh | 5 | 1.9% | 0.6 |
| LHAV4d1 (R) | 3 | unc | 5 | 1.9% | 0.6 |
| CB1901 (R) | 4 | ACh | 5 | 1.9% | 0.3 |
| LHPV4c4 (R) | 1 | Glu | 4 | 1.5% | 0.0 |
| LHAV3a1_c (R) | 1 | ACh | 4 | 1.5% | 0.0 |
| LHCENT2 (R) | 1 | GABA | 4 | 1.5% | 0.0 |
| CB1846 (R) | 2 | Glu | 4 | 1.5% | 0.5 |
| CB1178 (R) | 2 | Glu | 4 | 1.5% | 0.5 |
| SLP364 (R) | 2 | Glu | 4 | 1.5% | 0.5 |
| LHPV5a3 (R) | 2 | ACh | 4 | 1.5% | 0.0 |
| LHPV5g2 (R) | 1 | ACh | 3 | 1.1% | 0.0 |
| CB0943 (R) | 1 | ACh | 3 | 1.1% | 0.0 |
| CB2292 (R) | 1 | unc | 3 | 1.1% | 0.0 |
| LHPV6i1_a (R) | 1 | ACh | 3 | 1.1% | 0.0 |
| LHAV3b2_a (R) | 1 | ACh | 3 | 1.1% | 0.0 |
| SLP269 (R) | 1 | ACh | 3 | 1.1% | 0.0 |
| CB3173 (R) | 2 | ACh | 3 | 1.1% | 0.3 |
| CB1333 (R) | 2 | ACh | 3 | 1.1% | 0.3 |
| CB1595 (R) | 2 | ACh | 3 | 1.1% | 0.3 |
| LHAV3n1 (R) | 3 | ACh | 3 | 1.1% | 0.0 |
| CB3055 (R) | 1 | ACh | 2 | 0.7% | 0.0 |
| LHAV7a1_a (R) | 1 | Glu | 2 | 0.7% | 0.0 |
| SLP402_a (R) | 1 | Glu | 2 | 0.7% | 0.0 |
| CB1326 (R) | 1 | ACh | 2 | 0.7% | 0.0 |
| CB2346 (R) | 1 | Glu | 2 | 0.7% | 0.0 |
| CB1782 (R) | 1 | ACh | 2 | 0.7% | 0.0 |
| VM6_lvPN (R) | 1 | ACh | 2 | 0.7% | 0.0 |
| SLP160 (R) | 1 | ACh | 2 | 0.7% | 0.0 |
| SLP210 (R) | 1 | ACh | 2 | 0.7% | 0.0 |
| DC2_adPN (R) | 1 | ACh | 2 | 0.7% | 0.0 |
| SLP208 (R) | 1 | GABA | 2 | 0.7% | 0.0 |
| SMP183 (R) | 1 | ACh | 2 | 0.7% | 0.0 |
| DN1a (R) | 1 | Glu | 2 | 0.7% | 0.0 |
| CL135 (R) | 1 | ACh | 2 | 0.7% | 0.0 |
| LHPV4b3 (R) | 2 | Glu | 2 | 0.7% | 0.0 |
| LHAV3g2 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP387 (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| LHPD4d2_b (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| SLP412_b (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB4131 (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| SMP497 (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB2589 (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| CB4085 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| M_vPNml69 (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| CB1296_a (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| CB0973 (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| DM3_vPN (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| LHPV6f5 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB2920 (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB4119 (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB1181 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHPV5e2 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP334 (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB3556 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHPV4c3 (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| LHAD1b3 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHPV4c1_a (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB3293 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB1687 (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| LHPV6h2 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHAV4b4 (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| CB2563 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHAV6i2_b (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHAV2h1 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| FB1D (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| SLP368 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP365 (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| VP1l+VP3_ilPN (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| VA1d_adPN (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHAD1f2 (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 1 | 0.4% | 0.0 |